WO2004111019A3 - Groupement protecteur clivable par les albumines seriques - Google Patents
Groupement protecteur clivable par les albumines seriques Download PDFInfo
- Publication number
- WO2004111019A3 WO2004111019A3 PCT/FR2004/001466 FR2004001466W WO2004111019A3 WO 2004111019 A3 WO2004111019 A3 WO 2004111019A3 FR 2004001466 W FR2004001466 W FR 2004001466W WO 2004111019 A3 WO2004111019 A3 WO 2004111019A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- serumal
- protective groups
- albumins
- groups cleavable
- cleavable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0307094A FR2856060A1 (fr) | 2003-06-12 | 2003-06-12 | Groupement protecteur clivable par les albumines seriques |
FR03/07094 | 2003-06-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004111019A2 WO2004111019A2 (fr) | 2004-12-23 |
WO2004111019A3 true WO2004111019A3 (fr) | 2005-04-21 |
Family
ID=33484390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2004/001466 WO2004111019A2 (fr) | 2003-06-12 | 2004-06-11 | Groupement protecteur clivable par les albumines seriques |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2856060A1 (fr) |
WO (1) | WO2004111019A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115246934B (zh) * | 2022-01-26 | 2023-07-18 | 郑州大学第一附属医院 | 2-(1-甲基四氮唑)-4,5-咪唑二甲羧铁(ii)配合物及制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001081328A2 (fr) * | 2000-04-24 | 2001-11-01 | Aryx Therapeutics | Compositions et methodes destinees au traitement du diabete, de l'hyperlipidemie, de l'hypercholesterolemie et de l'atherosclerose |
WO2003024943A2 (fr) * | 2000-04-24 | 2003-03-27 | Aryx Therapeutics | Matieres et procedes pour le traitement de diabetes, de l'hyperlipidemie, de l'hypercholesterolemie, et de l'atherosclerose |
-
2003
- 2003-06-12 FR FR0307094A patent/FR2856060A1/fr not_active Withdrawn
-
2004
- 2004-06-11 WO PCT/FR2004/001466 patent/WO2004111019A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001081328A2 (fr) * | 2000-04-24 | 2001-11-01 | Aryx Therapeutics | Compositions et methodes destinees au traitement du diabete, de l'hyperlipidemie, de l'hypercholesterolemie et de l'atherosclerose |
WO2003024943A2 (fr) * | 2000-04-24 | 2003-03-27 | Aryx Therapeutics | Matieres et procedes pour le traitement de diabetes, de l'hyperlipidemie, de l'hypercholesterolemie, et de l'atherosclerose |
Also Published As
Publication number | Publication date |
---|---|
FR2856060A1 (fr) | 2004-12-17 |
WO2004111019A2 (fr) | 2004-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003093269A3 (fr) | Pyrazolopyrimidine-4-one substituee | |
WO2003074500A3 (fr) | Nouveaux composes | |
WO2006005609A3 (fr) | Derives d'oxindole substitues, et medicaments les renfermant | |
WO2003016282A3 (fr) | Nouveaux 1h-dihydropyrazoles substitues et leurs procedes de preparation et d'utilisation | |
MX2007006397A (es) | Derivados de tetrahidropirano. | |
CA2523831A1 (fr) | 5,7-diaminopyrazolo[4,3]d!pyrimidines utiles pour le traitement de l'hypertension | |
WO2004096798A3 (fr) | Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique | |
WO2004018451A8 (fr) | Derives de pyridazinone utilises comme inhibiteurs de pde4 | |
WO2007112028A3 (fr) | Phosphonates de 2'-fluoronucléoside en tant qu'agents antiviraux | |
WO2004014893A3 (fr) | Quinolones anti-microbiens, leurs compositions et utilisation | |
HK1087022A1 (en) | Dpp-iv inhibitors | |
WO2006103277A3 (fr) | Piperidines substituees | |
WO2004062613A3 (fr) | Inhibiteurs d'integrase hiv | |
WO2003008404A3 (fr) | Sels de sulfonium, procedes de preparation associes et utilisation de ces sels en tant que photoinitiateurs dans des systemes durcissables par rayonnement | |
WO2006072458A3 (fr) | Derives d'oxindol substitues, agents pharmaceutiques les contenant, et leur utilisation | |
WO2001082909A3 (fr) | Derives de 2-acyl-indole et leur utilisation comme agents antitumoraux | |
WO2006088903A3 (fr) | Composes pyrazole | |
WO2005110421A3 (fr) | Formulation d'aerosol pour l'inhalation de beta-agonistes | |
WO2006019955A3 (fr) | Methodes et compositions antivirales | |
WO2001098275A3 (fr) | 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides utilises comme agents antiviraux | |
WO2005051083A3 (fr) | Composes molluscicides et anti-anatifes | |
WO2005009348A3 (fr) | Derives de purine substitues | |
WO2006023586A3 (fr) | Composes de guanylhydrazone, compositions de guanylhydrazone, ainsi que leurs methodes de fabrication | |
TWI347948B (en) | Novel 2',5'-oligoadenylic acid compositions | |
WO2004056832A3 (fr) | Derives d'epothilone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |